Board Member
Beeline Holdings, Inc. (BLNE)Board Member
Pelthos Therapeutics Inc. (PTHS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Francis Knuettel is recorded as Board Member at Beeline Holdings, Inc. (BLNE) and Board Member at Pelthos Therapeutics Inc. (PTHS). Pelthos Therapeutics Inc. reported in an 8-K filed July 2, 2025 that Francis Knuettel was terminated as President, effective July 1, 2025. Pelthos Therapeutics Inc. reported in an 8-K filed July 2, 2025 that Francis Knuettel was terminated as Chief Executive Officer, effective July 1, 2025. The proxy statement of Pelthos Therapeutics Inc. reports total compensation of $307,010 for Francis Knuettel in fiscal 2023, including a base salary of $107,500. Francis Knuettel has spoken on 1 earnings call across 1 company, most recently for Pelthos Therapeutics Inc. on November 13, 2025.
“In connection with the Merger, on the Closing Date, Francis Knuettel’s employment as Chief Executive Officer, and President, Treasurer and Secretary of the Company terminated.”
“In connection with the Merger, on the Closing Date, Francis Knuettel’s employment as Chief Executive Officer, and President, Treasurer and Secretary of the Company terminated.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-01-01–present
Start not stated–present
Start not stated–2025-07-01
Start not stated–2026-04-10
Recorded roles and call appearances connecting this person to public companies.
Board Member
2024-01-01–present
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Pelthos Therapeutics Inc. (PTHS) | CEO | $107,500 | $307,010 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
